• Home > AbProfile
  • Overview

     

    Experience the first-ever working technology for antibody proteomics. Enabling reproducible, cost-effective and productive proteome-scale differential profiling for targets and biomarkers.

    DNA is script and protein is the actors of the biology.

    AbProfile™ is based on MabArray™ antibody array technology, a massively parallel, proprietary antibody array platform with close to 50,000 pre-made monoclonal antibodies. MabArray™ represents a fundamental breakthrough by solving the long-standing “content” problem of antibody array technology.

    AbProfile™'s current version covers 30-50% of any expressed proteome and the coverage will be expanded in to above 70% by doubling the library size to 100,000 monoclonal antibodies in 2015.